Teva Pharm announces approval of Alprazolam E.R. Tablets

Thu Mar 1, 2007 6:22am EST
 
[-] Text [+]
Co announces that the FDA has granted approval for the co's Abbreviated New Drug Application for Alprazolam Extended Release Tablets, 0.5 mg, 1 mg, 2 mg and 3 mg. Total annual sales of this product, including brand and generic sales, are approximately $54 million, based on IMS sales data.

 

Editor's Choice

A selection of our best photos from the past 24 hours.  Slideshow 

Most Popular on Reuters

  • Articles
  • Video
Join the Reuters Consumer Insight Panel and help us get to know you better

Join the Reuters Consumer Insight Panel and help us get to know you better